Obesity Linked to Financial Hardship, Food Insecurity
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 2, 2025 -- Obesity is associated with financial hardship and food insecurity, according to a research letter published online June 24 in the Annals of Internal Medicine.
Simar S. Bajaj, from the Stanford University School of Medicine in Palo Alto, California, and colleagues examined contemporary patterns of financial burden by obesity and overweight status in a repeated cross-sectional study using publicly available data from the National Health Interview Survey 2019 to 2023.
The final sample included 143,271 adults with normal weight (18.5 kg/m2 ≤ body mass index [BMI] < 25 kg/m2), overweight (25 kg/m2 ≤ BMI < 30 kg/m2), or obesity (BMI ≥ 30 kg/m2). The researchers found that compared with those with overweight and normal weight, people with obesity were more likely to report financial hardship (14.2 versus 9.2 and 8.2 percent) and food insecurity (9.5 versus 6.0 and 5.6 percent). Obesity was associated with financial hardship and food insecurity in the first Poisson regression model. Financial hardship was 0.89 percentage points higher among people with overweight versus those with normal weight in the second model, which also adjusted for socioeconomic variables. Compared with those with normal weight, among people with obesity, financial hardship was 3.96 percentage points higher and food insecurity was 1.74 percentage points higher. Compared with those with overweight and normal weight, people with obesity reported greater cost-related medication nonadherence (9.2 versus 6.4 and 6.1 percent).
"In unadjusted and multivariable analyses, obesity was independently associated with difficulty paying medical bills, food insecurity, and skipping medication because of cost," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Study Compares Benefits, Harms of Treatments for Chronic Hives
WEDNESDAY, July 23, 2025 -- Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study...
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.